VistaGen Therapeutics Inc. (VTGN)
Market Closed
1 Sep, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XMEX $
0. 24
-0.02
-6.4231%
$
11.32M Market Cap
- P/E Ratio
- Div Yield
590,801 Volume
-1.6 Eps
$ 0.26
Previous Close Want to track VTGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
VistaGen Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Dinan Hu R Squared Ltd | 27,745 | $21,086.2 | $6,686.54 | -$14,399.66 | -68.29% |
 Kathleen Thornhill Confluence Wealth Services Inc. | 32,610 | $24,783.6 | $7,826.4 | -$16,957.2 | -68.42% |
 Kevin Roan Stempoint Capita LLP | 616,749 | $1.8M | $166,522.24 | -$1.64M | -90.77% |
 Christopher C. Powers Farther Finance Advisors, LLC | 15,000 | $11,400 | $3,615 | -$7,785 | -68.29% |
 Douglas E. Morisoli Fairman Group, LLC | 29 | $149 | $6.96 | -$142.04 | -95.33% |
